Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Share-based Compensation (2016 - 2026)

Ironwood Pharmaceuticals' Share-based Compensation history spans 16 years, with the latest figure at $3.8 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 16.27% to $3.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $17.2 million, a 42.21% decrease, with the full-year FY2025 number at $17.2 million, down 42.21% from a year prior.
  • Share-based Compensation hit $3.8 million in Q4 2025 for Ironwood Pharmaceuticals, up from $3.6 million in the prior quarter.
  • Over the last five years, Share-based Compensation for IRWD hit a ceiling of $8.7 million in Q4 2023 and a floor of $3.6 million in Q3 2025.
  • Historically, Share-based Compensation has averaged $6.4 million across 5 years, with a median of $6.4 million in 2021.
  • Biggest five-year swings in Share-based Compensation: soared 43.84% in 2022 and later crashed 56.63% in 2025.
  • Tracing IRWD's Share-based Compensation over 5 years: stood at $6.1 million in 2021, then increased by 19.72% to $7.3 million in 2022, then rose by 19.38% to $8.7 million in 2023, then plummeted by 47.54% to $4.6 million in 2024, then fell by 16.27% to $3.8 million in 2025.
  • Business Quant data shows Share-based Compensation for IRWD at $3.8 million in Q4 2025, $3.6 million in Q3 2025, and $4.5 million in Q2 2025.